APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Surveillance Program

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Medical Surveillance Program Market Outlook and Growth Opportunities 2026

2 May 2026197 pages

Choose your research edition.

Industry ResearchMedical Surveillance Program Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Surveillance Program Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Medical Surveillance Program Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Surveillance Program Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Surveillance Program Market Analysis and Forecast 2026-2032240 pages · $4,950 USD

Market perspective

The global Medical Surveillance Program market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medical Surveillance Program is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Surveillance Program is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Surveillance Program is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medical Surveillance Program market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medical Surveillance Program market include ENTERPRISE HEALTH, VelocityEHS, Mobile Medical Corporation, Workplace Medical, Fusion Occupational Health, CORE, HSP Group, KINNECT and LifeLabs, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Medical Surveillance Program market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Surveillance Program and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Surveillance Program revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medical Surveillance Program market.

Medical Surveillance Program Segment by Company

ENTERPRISE HEALTH

VelocityEHS

Mobile Medical Corporation

Workplace Medical

Fusion Occupational Health

CORE

HSP Group

KINNECT

LifeLabs

Concentra

Work Health Solutions

Medical Surveillance Program Segment by Type

Biological Monitoring

Respiratory Protection

Substance Abuse Testing

Others

Medical Surveillance Program Segment by Application

SMEs

Large Enterprises

Medical Surveillance Program Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical Surveillance Program status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Medical Surveillance Program key companies, revenue, market share, and recent developments.

3. To split the Medical Surveillance Program breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Medical Surveillance Program market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical Surveillance Program significant trends, drivers, influence factors in global and regions.

6. To analyze Medical Surveillance Program competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Surveillance Program market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Surveillance Program and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Surveillance Program.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Surveillance Program industry.

Chapter 3: Detailed analysis of Medical Surveillance Program company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Medical Surveillance Program in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Medical Surveillance Program in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical Surveillance Program Industry Trends Table 2. Medical Surveillance Program Industry Drivers Table 3. Medical Surveillance Program Industry Opportunities and Challenges Table 4. Medical Surveillance Program Industry Restraints Table 5. Global Medical Surveillance Program Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical Surveillance Program Revenue Share by Company (2021-2026) Table 7. Global Medical Surveillance Program Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Medical Surveillance Program Key Company Manufacturing Base & Headquarters Table 9. Global Medical Surveillance Program Company, Product Type & Application Table 10. Global Medical Surveillance Program Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Medical Surveillance Program by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Biological Monitoring Table 15. Significant Companies of Respiratory Protection Table 16. Significant Companies of Substance Abuse Testing Table 17. Significant Companies of Others Table 18. Global Medical Surveillance Program Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Medical Surveillance Program Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Medical Surveillance Program Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Medical Surveillance Program Sales Value Share by Type (2021-2026) Table 22. Global Medical Surveillance Program Sales Value Share by Type (2027-2032) Table 23. Significant Companies of SMEs Table 24. Significant Companies of Large Enterprises Table 25. Global Medical Surveillance Program Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Medical Surveillance Program Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Medical Surveillance Program Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Medical Surveillance Program Sales Value Share by Application (2021-2026) Table 29. Global Medical Surveillance Program Sales Value Share by Application (2027-2032) Table 30. Global Medical Surveillance Program Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Medical Surveillance Program Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Medical Surveillance Program Sales Value Share by Region (2021-2026) Table 33. Global Medical Surveillance Program Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Medical Surveillance Program Sales Value Share by Region (2027-2032) Table 35. Global Medical Surveillance Program Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Medical Surveillance Program Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Medical Surveillance Program Sales Value Market Share by Country (2021-2026) Table 38. Global Medical Surveillance Program Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Medical Surveillance Program Sales Value Market Share by Country (2027-2032) Table 40. ENTERPRISE HEALTH Company Information Table 41. ENTERPRISE HEALTH Business Overview Table 42. ENTERPRISE HEALTH Medical Surveillance Program Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. ENTERPRISE HEALTH Medical Surveillance Program Product Portfolio Table 44. ENTERPRISE HEALTH Recent Development Table 45. VelocityEHS Company Information Table 46. VelocityEHS Business Overview Table 47. VelocityEHS Medical Surveillance Program Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. VelocityEHS Medical Surveillance Program Product Portfolio Table 49. VelocityEHS Recent Development Table 50. Mobile Medical Corporation Company Information Table 51. Mobile Medical Corporation Business Overview Table 52. Mobile Medical Corporation Medical Surveillance Program Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Mobile Medical Corporation Medical Surveillance Program Product Portfolio Table 54. Mobile Medical Corporation Recent Development Table 55. Workplace Medical Company Information Table 56. Workplace Medical Business Overview Table 57. Workplace Medical Medical Surveillance Program Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Workplace Medical Medical Surveillance Program Product Portfolio Table 59. Workplace Medical Recent Development Table 60. Fusion Occupational Health Company Information Table 61. Fusion Occupational Health Business Overview Table 62. Fusion Occupational Health Medical Surveillance Program Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Fusion Occupational Health Medical Surveillance Program Product Portfolio Table 64. Fusion Occupational Health Recent Development Table 65. CORE Company Information Table 66. CORE Business Overview Table 67. CORE Medical Surveillance Program Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. CORE Medical Surveillance Program Product Portfolio Table 69. CORE Recent Development Table 70. HSP Group Company Information Table 71. HSP Group Business Overview Table 72. HSP Group Medical Surveillance Program Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. HSP Group Medical Surveillance Program Product Portfolio Table 74. HSP Group Recent Development Table 75. KINNECT Company Information Table 76. KINNECT Business Overview Table 77. KINNECT Medical Surveillance Program Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. KINNECT Medical Surveillance Program Product Portfolio Table 79. KINNECT Recent Development Table 80. LifeLabs Company Information Table 81. LifeLabs Business Overview Table 82. LifeLabs Medical Surveillance Program Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. LifeLabs Medical Surveillance Program Product Portfolio Table 84. LifeLabs Recent Development Table 85. Concentra Company Information Table 86. Concentra Business Overview Table 87. Concentra Medical Surveillance Program Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Concentra Medical Surveillance Program Product Portfolio Table 89. Concentra Recent Development Table 90. Work Health Solutions Company Information Table 91. Work Health Solutions Business Overview Table 92. Work Health Solutions Medical Surveillance Program Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Work Health Solutions Medical Surveillance Program Product Portfolio Table 94. Work Health Solutions Recent Development Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Medical Surveillance Program Product Image Figure 2. Global Medical Surveillance Program Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Surveillance Program Market Size (2021-2032) & (US$ Million) Figure 4. Global Medical Surveillance Program Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Biological Monitoring Image Figure 8. Respiratory Protection Image Figure 9. Substance Abuse Testing Image Figure 10. Others Image Figure 11. Global Medical Surveillance Program Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Medical Surveillance Program Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Medical Surveillance Program Sales Value Share by Type (2021-2032) Figure 14. SMEs Image Figure 15. Large Enterprises Image Figure 16. Global Medical Surveillance Program Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Medical Surveillance Program Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Medical Surveillance Program Sales Value Share by Application (2021-2032) Figure 19. Global Medical Surveillance Program Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Medical Surveillance Program Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Medical Surveillance Program Sales Value (2021-2032) & (US$ Million) Figure 22. North America Medical Surveillance Program Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Medical Surveillance Program Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Medical Surveillance Program Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Medical Surveillance Program Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Medical Surveillance Program Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Medical Surveillance Program Sales Value (2021-2032) & (US$ Million) Figure 28. South America Medical Surveillance Program Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Medical Surveillance Program Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Medical Surveillance Program Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Medical Surveillance Program Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Biological Monitoring
  • Respiratory Protection
  • Substance Abuse Testing
  • Others
Applications
  • SMEs
  • Large Enterprises
Companies covered
  • ENTERPRISE HEALTH
  • VelocityEHS
  • Mobile Medical Corporation
  • Workplace Medical
  • Fusion Occupational Health
  • CORE
  • HSP Group
  • KINNECT
  • LifeLabs
  • Concentra
  • Work Health Solutions

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Medical Surveillance Program Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Medical Surveillance Program Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Medical Surveillance Program Market Dynamics
  1. 2.1 Medical Surveillance Program Industry Trends
  2. 2.2 Medical Surveillance Program Industry Drivers
  3. 2.3 Medical Surveillance Program Industry Opportunities and Challenges
  4. 2.4 Medical Surveillance Program Industry Restraints
3 Medical Surveillance Program Market by Company
  1. 3.1 Global Medical Surveillance Program Company Revenue Ranking in 2025
  2. 3.2 Global Medical Surveillance Program Revenue by Company (2021-2026)
  3. 3.3 Global Medical Surveillance Program Company Ranking (2024-2026)
  4. 3.4 Global Medical Surveillance Program Company Manufacturing Base and Headquarters
  5. 3.5 Global Medical Surveillance Program Company Product Type and Application
  6. 3.6 Global Medical Surveillance Program Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Medical Surveillance Program Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Medical Surveillance Program Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Medical Surveillance Program Market by Type
  1. 4.1 Medical Surveillance Program Type Introduction
  2. 4.1.1 Biological Monitoring
  3. 4.1.2 Respiratory Protection
  4. 4.1.3 Substance Abuse Testing
  5. 4.1.4 Others
  6. 4.2 Global Medical Surveillance Program Sales Value by Type
  7. 4.2.1 Global Medical Surveillance Program Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Medical Surveillance Program Sales Value by Type (2021-2032)
  9. 4.2.3 Global Medical Surveillance Program Sales Value Share by Type (2021-2032)
5 Medical Surveillance Program Market by Application
  1. 5.1 Medical Surveillance Program Application Introduction
  2. 5.1.1 SMEs
  3. 5.1.2 Large Enterprises
  4. 5.2 Global Medical Surveillance Program Sales Value by Application
  5. 5.2.1 Global Medical Surveillance Program Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Medical Surveillance Program Sales Value by Application (2021-2032)
  7. 5.2.3 Global Medical Surveillance Program Sales Value Share by Application (2021-2032)
6 Medical Surveillance Program Regional Value Analysis
  1. 6.1 Global Medical Surveillance Program Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Surveillance Program Sales Value by Region (2021-2032)
  3. 6.2.1 Global Medical Surveillance Program Sales Value by Region: 2021-2026
  4. 6.2.2 Global Medical Surveillance Program Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medical Surveillance Program Sales Value (2021-2032)
  7. 6.3.2 North America Medical Surveillance Program Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Medical Surveillance Program Sales Value (2021-2032)
  10. 6.4.2 Europe Medical Surveillance Program Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Medical Surveillance Program Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Medical Surveillance Program Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Medical Surveillance Program Sales Value (2021-2032)
  16. 6.6.2 South America Medical Surveillance Program Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Medical Surveillance Program Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Medical Surveillance Program Sales Value Share by Country, 2025 VS 2032
7 Medical Surveillance Program Country-level Value Analysis
  1. 7.1 Global Medical Surveillance Program Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical Surveillance Program Sales Value by Country (2021-2032)
  3. 7.2.1 Global Medical Surveillance Program Sales Value by Country (2021-2026)
  4. 7.2.2 Global Medical Surveillance Program Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Medical Surveillance Program Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Medical Surveillance Program Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Medical Surveillance Program Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ENTERPRISE HEALTH
  2. 8.1.1 ENTERPRISE HEALTH Company Information
  3. 8.1.2 ENTERPRISE HEALTH Business Overview
  4. 8.1.3 ENTERPRISE HEALTH Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ENTERPRISE HEALTH Medical Surveillance Program Product Portfolio
  6. 8.1.5 ENTERPRISE HEALTH Recent Developments
  7. 8.2 VelocityEHS
  8. 8.2.1 VelocityEHS Company Information
  9. 8.2.2 VelocityEHS Business Overview
  10. 8.2.3 VelocityEHS Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  11. 8.2.4 VelocityEHS Medical Surveillance Program Product Portfolio
  12. 8.2.5 VelocityEHS Recent Developments
  13. 8.3 Mobile Medical Corporation
  14. 8.3.1 Mobile Medical Corporation Company Information
  15. 8.3.2 Mobile Medical Corporation Business Overview
  16. 8.3.3 Mobile Medical Corporation Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mobile Medical Corporation Medical Surveillance Program Product Portfolio
  18. 8.3.5 Mobile Medical Corporation Recent Developments
  19. 8.4 Workplace Medical
  20. 8.4.1 Workplace Medical Company Information
  21. 8.4.2 Workplace Medical Business Overview
  22. 8.4.3 Workplace Medical Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Workplace Medical Medical Surveillance Program Product Portfolio
  24. 8.4.5 Workplace Medical Recent Developments
  25. 8.5 Fusion Occupational Health
  26. 8.5.1 Fusion Occupational Health Company Information
  27. 8.5.2 Fusion Occupational Health Business Overview
  28. 8.5.3 Fusion Occupational Health Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Fusion Occupational Health Medical Surveillance Program Product Portfolio
  30. 8.5.5 Fusion Occupational Health Recent Developments
  31. 8.6 CORE
  32. 8.6.1 CORE Company Information
  33. 8.6.2 CORE Business Overview
  34. 8.6.3 CORE Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CORE Medical Surveillance Program Product Portfolio
  36. 8.6.5 CORE Recent Developments
  37. 8.7 HSP Group
  38. 8.7.1 HSP Group Company Information
  39. 8.7.2 HSP Group Business Overview
  40. 8.7.3 HSP Group Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  41. 8.7.4 HSP Group Medical Surveillance Program Product Portfolio
  42. 8.7.5 HSP Group Recent Developments
  43. 8.8 KINNECT
  44. 8.8.1 KINNECT Company Information
  45. 8.8.2 KINNECT Business Overview
  46. 8.8.3 KINNECT Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  47. 8.8.4 KINNECT Medical Surveillance Program Product Portfolio
  48. 8.8.5 KINNECT Recent Developments
  49. 8.9 LifeLabs
  50. 8.9.1 LifeLabs Company Information
  51. 8.9.2 LifeLabs Business Overview
  52. 8.9.3 LifeLabs Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  53. 8.9.4 LifeLabs Medical Surveillance Program Product Portfolio
  54. 8.9.5 LifeLabs Recent Developments
  55. 8.10 Concentra
  56. 8.10.1 Concentra Company Information
  57. 8.10.2 Concentra Business Overview
  58. 8.10.3 Concentra Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Concentra Medical Surveillance Program Product Portfolio
  60. 8.10.5 Concentra Recent Developments
  61. 8.11 Work Health Solutions
  62. 8.11.1 Work Health Solutions Company Information
  63. 8.11.2 Work Health Solutions Business Overview
  64. 8.11.3 Work Health Solutions Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Work Health Solutions Medical Surveillance Program Product Portfolio
  66. 8.11.5 Work Health Solutions Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst